Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 37

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 37
---
) at the time of such termination, certain of the closing conditions set forth in the Divestiture Agreement have not been satisfied;   
 (3) prior to the termination of the Divestiture Agreement, an acquisition proposal to engage in an Acquisition Transaction (except that all references to “fifteen percent” in the definition of Acquisition Transaction in the               
 Divestiture Agreement will be deemed to be references to “fifty percent”) is received from any person other than Kaken or any of its affiliates has been publicly announced or publicly disclosed and not withdrawn or otherwise abandoned at 
 within a certain period prior to the termination of the Divestiture Agreement; and (4) within one year of the termination of the Divestiture Agreement, either an Acquisition Transaction (except that all references to “fifteen percent”    
 in the definition of Acquisition Transaction in the Divestiture Agreement will be deemed to be references to “fifty percent”) is consummated or Aadi or Aadi Sub enter into a definitive agreement providing for the consummation of such a   
 transaction and it is subsequently completed;                                                                                                                                                                                                 |

| • |     | the Divestiture Agreement is terminated by Kaken after Aadi’s board of directors changes its recommendation 
 with respect to the Divestiture;                                                                            |

| • |     | the Divestiture Agreement is terminated by Aadi, prior to the approval of the Divestiture Agreement and the                                                                                                                              
 Divestiture by the requisite affirmative vote of Aadi stockholders, if (1) Aadi has received a Superior Proposal; (2) Aadi’s board of directors has authorized Aadi to enter into an Alternative Acquisition Agreement to consummate the 
 acquisition transaction contemplated by such Superior Proposal; and (3) Aadi has complied in all material respects with its obligations under the Superior Proposal provisions in the Divestiture Agreement; or                          |

| • |     | (1) the Divestiture Agreement is terminated by either Kaken or Aadi, and (2) prior to such termination, at              
 the Special Meeting, Aadi stockholders have failed to approve the other transactions set forth in this proxy statement. |

The Divestiture Agreement also provides that Aadi, on the one hand, or Kaken, on the other hand, may specifically enforce the obligations under the Divestiture Agreement, except that a party may only cause the other party to complete the Divestiture if certain conditions are satisfied. Subject to limited exceptions, Aadi’s aggregate liability for monetary damages for breaches